MX9604391A - Anticuerpos monoclonales que reconocen el receptor de tie y su uso. - Google Patents

Anticuerpos monoclonales que reconocen el receptor de tie y su uso.

Info

Publication number
MX9604391A
MX9604391A MX9604391A MX9604391A MX9604391A MX 9604391 A MX9604391 A MX 9604391A MX 9604391 A MX9604391 A MX 9604391A MX 9604391 A MX9604391 A MX 9604391A MX 9604391 A MX9604391 A MX 9604391A
Authority
MX
Mexico
Prior art keywords
antibodies
tie
monoclonal antibodies
useful
receptor
Prior art date
Application number
MX9604391A
Other languages
English (en)
Inventor
Kari Alitalo
Marja-Terttu Matikainen
Paivi Karnani
Original Assignee
Kari Alitalo
Marja-Terttu Matikainen
Paivi Karnani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kari Alitalo, Marja-Terttu Matikainen, Paivi Karnani filed Critical Kari Alitalo
Publication of MX9604391A publication Critical patent/MX9604391A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen anticuerpos novedosos, los cuales son reactivos con Tie, una cinasa de tirosina receptora encontrada en células endoteliales y en ciertas poblaciones celulares tumorosas. Se describen los anticuerpos monoclonales de anti-Tie y se proporciona el anticuerpo monoclonal 3C4C7G6, así como la línea celular de hibridoma (DSM ACCC2159) que lo produce. Los anticuerpos son utiles como herramientas de diagnostico para la deteccion de enfermedades neoplásticas que involucran angiogénesis tumorosa, curacion de heridas y una variedad de otras enfermedades asociadas con angiogénesis y para la representacion radiologica de los vasos sanguíneos. Además, los anticuerpos expuestos son utiles como agentes terapéuticos.
MX9604391A 1994-03-29 1995-03-29 Anticuerpos monoclonales que reconocen el receptor de tie y su uso. MX9604391A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/220,240 US5955291A (en) 1992-01-09 1994-03-29 Antibodies recognizing tie receptor tyrosine kinase and uses thereof
PCT/FI1995/000170 WO1995026364A1 (en) 1994-03-29 1995-03-29 Monoclonal antibodies recognizing tie-receptor and their use

Publications (1)

Publication Number Publication Date
MX9604391A true MX9604391A (es) 1997-07-31

Family

ID=22822698

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604391A MX9604391A (es) 1994-03-29 1995-03-29 Anticuerpos monoclonales que reconocen el receptor de tie y su uso.

Country Status (13)

Country Link
US (1) US5955291A (es)
EP (1) EP0753015B1 (es)
JP (1) JP3683270B2 (es)
AT (1) ATE195533T1 (es)
AU (1) AU697185B2 (es)
CA (1) CA2185043C (es)
DE (1) DE69518406T2 (es)
DK (1) DK0753015T3 (es)
ES (1) ES2151595T3 (es)
MX (1) MX9604391A (es)
NO (1) NO319586B1 (es)
NZ (1) NZ283366A (es)
WO (1) WO1995026364A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
US6818220B1 (en) 1994-11-14 2004-11-16 Licentia Ltd. Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof
ATE273384T1 (de) 1995-04-06 2004-08-15 Regeneron Pharma Tie-2 liganden, herstellungsverfahren und verwendung
US6361946B1 (en) 1997-02-05 2002-03-26 Licentia Ltd Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
US7423125B2 (en) 1995-08-01 2008-09-09 Vegenics Limited Antibodies to VEGF-C
US7063965B2 (en) 1996-04-05 2006-06-20 Regeneron Pharmaceuticals, Inc. Nucleic acid encoding TIE-2 ligand
US5851797A (en) * 1996-06-19 1998-12-22 Regeneron Pharmaceuticals, Inc. Tie ligand-3, methods of making and uses thereof
US7125714B2 (en) 1997-02-05 2006-10-24 Licentia Ltd. Progenitor cell materials and methods
US5972338A (en) 1997-09-19 1999-10-26 Genentech, Inc. Tie ligands homologues
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6350450B1 (en) 1997-09-19 2002-02-26 Genentech, Inc. TIE ligand homologue antibody
US6348350B1 (en) 1997-09-19 2002-02-19 Genentech, Inc. Ligand homologues
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
FR2783325A1 (fr) * 1998-09-11 2000-03-17 Inst Nat Sante Rech Med Moyens pour le controle de la regulation negative d'une activation transmise par un rtk
US6365154B1 (en) * 1998-09-28 2002-04-02 Smithkline Beecham Corporation Tie2 agonist antibodies
US6376653B1 (en) * 1998-09-28 2002-04-23 Smithkline Beecham Plc Tie2 antagonist antibodies
US7488590B2 (en) * 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
AU783960B2 (en) 1999-06-07 2006-01-05 Immunex Corporation Tek antagonists
US6521424B2 (en) * 1999-06-07 2003-02-18 Immunex Corporation Recombinant expression of Tek antagonists
US6346247B1 (en) 1999-10-28 2002-02-12 Promega Corporation Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
DE60131146T2 (de) 2000-02-25 2008-03-06 Ludwig Institute For Cancer Research Material und verfahren die hybridvaskularendothelwachstumfaktoren dns und proteine enthalten und screeningverfahren für modulatoren
WO2001072339A2 (en) * 2000-03-30 2001-10-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treatment of conditions involving obstruction of blood flow
WO2002036771A2 (en) 2000-11-06 2002-05-10 Cancer Research Technology Limited Imaging, diagnosis and treatment of disease
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7138370B2 (en) * 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US20050152899A1 (en) * 2002-05-10 2005-07-14 Kinch Michael S. EphA2 agonistic monoclonal antibodies and methods of use thereof
WO2003094859A2 (en) * 2002-05-10 2003-11-20 Medimmune, Inc. Epha2 monoclonal antibodies and methods of use thereof
JP4585968B2 (ja) * 2002-05-10 2010-11-24 パーデュー・リサーチ・ファウンデーション ＥｐｈＡ２アゴニストモノクローナル抗体およびその使用法
DK1458853T3 (da) * 2002-05-16 2010-04-06 Absorber Ab Fremgangsmåde til donorspecifik krydsmatchning
EP1565491B1 (en) 2002-11-20 2010-03-31 Cancer Research Technology Limited Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
CA2521594A1 (en) * 2003-04-11 2004-10-28 Medimmune, Inc. Epha2 and non-neoplastic hyperproliferative cell disorders
EP1618184A4 (en) * 2003-04-11 2006-06-21 Medimmune Inc EPHA2, HYPOPROLIFERATIVE CELL DISORDERS, AND EPITHELIAL AND ENDOTHELIAL RECONSTITUTION
EP1479760A1 (de) * 2003-05-19 2004-11-24 ProBioGen AG Künstliches Immunorgan
WO2005019267A2 (en) * 2003-08-12 2005-03-03 Dyax Corp. Tie1-binding ligands
US7485297B2 (en) * 2003-08-12 2009-02-03 Dyax Corp. Method of inhibition of vascular development using an antibody
US7871610B2 (en) * 2003-08-12 2011-01-18 Dyax Corp. Antibodies to Tie1 ectodomain
CA2550551C (en) * 2004-01-16 2013-10-29 Regeneron Pharmaceuticals, Inc. Fusion polypeptides capable of activating receptors
US8298532B2 (en) 2004-01-16 2012-10-30 Regeneron Pharmaceuticals, Inc. Fusion polypeptides capable of activating receptors
CA2559110A1 (en) * 2004-03-09 2005-09-15 Absorber Ab Endothelial progenitor cells and methods of use thereof
EP1789451A4 (en) * 2004-08-12 2009-12-02 Dyax Corp TIE COMPLEX BINDING PROTEINS
US20090170769A1 (en) * 2005-05-13 2009-07-02 Pei Jin Cell surface receptor isoforms and methods of identifying and using the same
US20080213253A1 (en) * 2007-01-12 2008-09-04 Dyax Corp. Combination therapy for the treatment of cancer
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US9896933B1 (en) 2011-02-07 2018-02-20 Ameriband, Llc Continuously variable displacement engine
US9540932B1 (en) 2011-02-07 2017-01-10 Ameriband, Llc Continuously variable displacement engine
US9109446B1 (en) 2011-02-07 2015-08-18 Ameriband, Llc Continuously variable displacement engine
US10041405B1 (en) 2011-02-07 2018-08-07 Ameriband, Llc Continuously variable displacement engine
US9581057B1 (en) 2014-08-20 2017-02-28 Ameriband, Llc Valve actuator system capable of operating multiple valves with a single cam

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
EP0620826A1 (en) * 1992-01-09 1994-10-26 Helsinki University Holding, Ltd. Tie, a novel endothelial cell receptor tyrosine kinase

Also Published As

Publication number Publication date
DE69518406D1 (de) 2000-09-21
NO964013D0 (no) 1996-09-24
NO319586B1 (no) 2005-08-29
DE69518406T2 (de) 2001-03-15
WO1995026364A1 (en) 1995-10-05
JP3683270B2 (ja) 2005-08-17
EP0753015A1 (en) 1997-01-15
ES2151595T3 (es) 2001-01-01
CA2185043A1 (en) 1995-10-05
EP0753015B1 (en) 2000-08-16
NO964013L (no) 1996-09-24
AU2139295A (en) 1995-10-17
ATE195533T1 (de) 2000-09-15
US5955291A (en) 1999-09-21
AU697185B2 (en) 1998-10-01
JPH09511141A (ja) 1997-11-11
DK0753015T3 (da) 2000-11-13
NZ283366A (en) 1998-04-27
CA2185043C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
MX9604391A (es) Anticuerpos monoclonales que reconocen el receptor de tie y su uso.
AU7690596A (en) Anti-CD6 monoclonal antibodies and their uses
DE3750389D1 (de) Antikörper gegen menschlichen progesteronrezeptor sowie diagnosematerial und -verfahren.
AU4725796A (en) Preparation and use of a specific gaba-A alpha 5 receptor ligand for treatment of Alzheimer's disease
ZA943464B (en) Vascular endothelial growth factor 2
EP0253202A3 (en) Novel immunoconjugates and methods for their use in tumor therapy
EP0888125A4 (en) HUMANIZED GLYCOSYL ANTIBODIES SPECIFIC TO B-LYMPHOCYTES
HUP0200537A2 (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
NZ288235A (en) Monoclonal antibody directed against the receptor tyrosine kinase flt4 and use in diagnosis and therapy
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
AU2709295A (en) Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
CA2045552A1 (en) Cancer related haptoglobin
ES8704082A1 (es) Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.
IT1264083B1 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
ES2000615A6 (es) Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
EP0166458A3 (en) Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
AU1190388A (en) Methods and materials for hiv detection and therapy
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis
ES2059539T3 (es) Metodo para la prevencion de la enfermedad del injerto frente al huesped.
EP0767673A4 (en) METHODS FOR REDUCED RENAL ABSORPTION OF ANTIBODY FRAGMENTS
GB9100741D0 (en) Treatment of disease
GB9927125D0 (en) Placental human neurokinin B precursor
GB2397018A (en) Combination therapy for treating disease
BG50103A1 (en) Hybridome cell line, secretting monoclonal antibody against antigene determinante noc- 2 of malignant melanom in human
ATE169332T1 (de) Monoklonaler antikörper gegen den extravillösen trophoblast

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: LICENTIA LTD.

MM Annulment or lapse due to non-payment of fees